Join to view full profile
Massachusetts General Hospital55 Fruit StreetBoston, MA 02114
Phone+1 617-726-2967
Dr. Khor is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 2007 - 2011
WashU MedicineClass of 2007
Certifications & Licensure
WA State Medical License 2016 - 2027
MA State Medical License 2011 - 2018
American Board of Pathology Pathology - Clinical- American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- 12 citationsFRTX-02, a selective and potent inhibitor of DYRK1A, modulates inflammatory pathways in mouse models of psoriasis and atopic dermatitis.Soochan Kim, Eunhwa Ko, Hwan Geun Choi, Daekwon Kim, Monica Luchi
Journal of Translational Autoimmunity. 2023-01-01 - 5 citationsThe Cyclin-Dependent Kinase 8 (CDK8) Inhibitor DCA Promotes a Tolerogenic Chemical Immunophenotype in CD4+ T Cells via a Novel CDK8-GATA3-FOXP3 Pathway.Azlann Arnett, Keagan G. Moo, Kaitlin J. Flynn, Thomas B. Sundberg, Liv Johannessen
Molecular and Cellular Biology. 2021-08-24 - 24 citationsTonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiomeIsabelle Marié, Lara Brambilla, Doua F Azzouz, Ze Chen, Gisele V Baracho
Elife. 2021-08-11
Press Mentions
Autoimmunity in down Syndrome Arises from Rapid Immune AgingJanuary 14th, 2022- Does the Vaccine Cut Your Risk of Getting Long COVID?October 21st, 2021
- Brickell Biotech to Host Key Opinion Leader Webinar on DYRK1A and Its Role in AutoimmunitySeptember 17th, 2021
Grant Support
- Dissecting how DYRK1A-gp130 axis drives immune dysregulation in Down syndrome and beyondBENAROYA RESEARCH INST AT VIRGINIA MASON2026–2028
- Dissecting how DYRK1A-gp130 axis drives immune dysregulation in Down syndrome and beyondBENAROYA RESEARCH INST AT VIRGINIA MASON2026–2028
- Dissecting how DYRK1A-gp130 axis drives immune dysregulation in Down syndrome and beyondBENAROYA RESEARCH INST AT VIRGINIA MASON2026–2028
- Mechanistic and functional dissection of inflammaging in Down syndromeBENAROYA RESEARCH INST AT VIRGINIA MASON2022–2027
- Mechanistic and functional dissection of inflammaging in Down syndromeBENAROYA RESEARCH INST AT VIRGINIA MASON2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
